Shares of Johnson & Johnson (NYS:JNJ) dropped 0.73% to $166.88 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index (S&P:SPX) falling 1.59% to 4,258.49 and Dow Jones Industrial Average (DOW:DJIA) falling 2.09% to 33,962.04. This was the stock's third consecutive day of losses. Johnson & Johnson closed $6.77 below its 52-week high ($173.65), which the company reached on January 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Roche Holding AG Part. Cert. (OTC:RHHVF) fell 1.74% to $381.72, Merck & Co. Inc. (NYS:MRK) fell 1.24% to $77.05, and Pfizer Inc. (NYS:PFE) fell 0.50% to $40.15. Trading volume (8.2 M) eclipsed its 50-day average volume of 6.4 M.